Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Rheumatoid Arthritis

  Free Subscription


Articles published in Rheumatol Int

Retrieve available abstracts of 196 articles:
HTML format



Single Articles


    May 2020
  1. HARROLD LR, Shan Y, Rebello S, Kramer N, et al
    Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjogren's syndrome enrolled in a large observational US registry.
    Rheumatol Int. 2020 May 24. pii: 10.1007/s00296-020-04602.
    PubMed     Abstract available


  2. LINDNER L, Callhoff J, Alten R, Krause A, et al
    Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.
    Rheumatol Int. 2020 May 6. pii: 10.1007/s00296-020-04593.
    PubMed     Abstract available


  3. GEORGIEV T
    Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
    Rheumatol Int. 2020;40:825-826.
    PubMed    


    April 2020
  4. CHUNG TT, Ko HJ, Lau CS, Chung HY, et al
    A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis.
    Rheumatol Int. 2020 Apr 21. pii: 10.1007/s00296-020-04583.
    PubMed     Abstract available


  5. SONG J, Kang S, Choi SW, Seo KW, et al
    Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs.
    Rheumatol Int. 2020 Apr 20. pii: 10.1007/s00296-020-04584.
    PubMed     Abstract available


  6. AYAN G, Esatoglu SN, Hatemi G, Hamuryudan V, et al
    Disease course and healthcare costs of a cohort of rheumatoid arthritis patients from Turkey.
    Rheumatol Int. 2020 Apr 6. pii: 10.1007/s00296-020-04574.
    PubMed     Abstract available


  7. OLAH C, Kardos Z, Kostyal L, Hodosi K, et al
    Correction to: Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study.
    Rheumatol Int. 2020 Apr 4. pii: 10.1007/s00296-020-04572.
    PubMed     Abstract available


  8. BENSON R, Zhao SS, Goodson N, Abernethy R, et al
    Correction to: Biologic monotherapy in the biologic naive patient with rheumatoid arthritis (RA): results from an observational study.
    Rheumatol Int. 2020 Apr 2. pii: 10.1007/s00296-020-04556.
    PubMed     Abstract available


    March 2020
  9. CSABA O, Kardos Z, Kostyal L, Hodosi K, et al
    Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study.
    Rheumatol Int. 2020 Mar 16. pii: 10.1007/s00296-020-04549.
    PubMed     Abstract available


  10. LEE JS, Oh JS, Kim YG, Lee CK, et al
    Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction.
    Rheumatol Int. 2020 Mar 13. pii: 10.1007/s00296-020-04547.
    PubMed     Abstract available


    February 2020
  11. WEIJERS JM, Semb AG, Rollefstad S, Kitas GD, et al
    Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers.
    Rheumatol Int. 2020 Feb 22. pii: 10.1007/s00296-020-04533.
    PubMed     Abstract available


  12. BENSON R, Zhao SS, Goodson N, Abernethy R, et al
    Biologic monotherapy in the biologic naive patient with rheumatoid arthritis (RA): results from an observational study.
    Rheumatol Int. 2020 Feb 21. pii: 10.1007/s00296-020-04531.
    PubMed     Abstract available


  13. PFLUGBEIL S, Bockl K, Pongratz R, Leitner M, et al
    Drug interactions in the treatment of rheumatoid arthritis and psoriatic arthritis.
    Rheumatol Int. 2020 Feb 12. pii: 10.1007/s00296-020-04526.
    PubMed     Abstract available


  14. KOEHM M, McIntosh MJ, Hofmann MW, Abraham V, et al
    Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies.
    Rheumatol Int. 2020 Feb 10. pii: 10.1007/s00296-020-04514.
    PubMed     Abstract available


  15. CHUNG SW, Park EH, Kang EH, Lee YJ, et al
    Diffuse large B-cell lymphoma involving the left sternoclavicular joint mimicking rheumatoid arthritis flare: a case-based review.
    Rheumatol Int. 2020 Feb 8. pii: 10.1007/s00296-020-04528.
    PubMed     Abstract available


  16. ZAICHKO K, Stanislavchuk M, Zaichko N
    Circadian fluctuations of endothelial nitric oxide synthase activity in females with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2020 Feb 5. pii: 10.1007/s00296-020-04525.
    PubMed     Abstract available


    January 2020
  17. SZEKANECZ Z
    Reply to: Comment on "effects of 1-year anti-TNF-alpha therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis" by Cure et al.
    Rheumatol Int. 2020 Jan 30. pii: 10.1007/s00296-020-04521.
    PubMed    


  18. CURE E, Cumhur Cure M
    Comment on "Effects of 1-year anti-TNF-alpha therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis".
    Rheumatol Int. 2020 Jan 18. pii: 10.1007/s00296-020-04513.
    PubMed    


  19. XU S, Liang Y, Meng F, Zhu Z, et al
    Risk prediction of degenerative scoliosis combined with lumbar spinal stenosis in patients with rheumatoid arthritis: a case-control study.
    Rheumatol Int. 2020 Jan 9. pii: 10.1007/s00296-019-04508.
    PubMed     Abstract available


  20. DAVIDA L, Pongracz V, Mohamed EA, Szamosi S, et al
    Correction to: A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis.
    Rheumatol Int. 2020 Jan 6. pii: 10.1007/s00296-019-04509.
    PubMed     Abstract available


    December 2019
  21. DAVIDA L, Pongracz V, Mohamed EA, Szamosi S, et al
    A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis.
    Rheumatol Int. 2019 Dec 19. pii: 10.1007/s00296-019-04503.
    PubMed     Abstract available


  22. VEGH E, Kerekes G, Pusztai A, Hamar A, et al
    Effects of 1-year anti-TNF-alpha therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
    Rheumatol Int. 2019 Dec 17. pii: 10.1007/s00296-019-04497.
    PubMed     Abstract available


  23. GROSSE J, Allado E, Roux C, Pierreisnard A, et al
    ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography.
    Rheumatol Int. 2019 Dec 13. pii: 10.1007/s00296-019-04492.
    PubMed     Abstract available


  24. METSIOS GS, Moe RH, van der Esch M, van Zanten JJCSV, et al
    The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis.
    Rheumatol Int. 2019 Dec 4. pii: 10.1007/s00296-019-04483.
    PubMed     Abstract available


    November 2019
  25. BIALOWAS K, Radwan-Oczko M, Dus-Ilnicka I, Korman L, et al
    Periodontal disease and influence of periodontal treatment on disease activity in patients with rheumatoid arthritis and spondyloarthritis.
    Rheumatol Int. 2019 Nov 7. pii: 10.1007/s00296-019-04460.
    PubMed     Abstract available


    October 2019
  26. MURATA K, Hashimoto M, Yamamoto W, Son Y, et al
    The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER co
    Rheumatol Int. 2019 Oct 16. pii: 10.1007/s00296-019-04464.
    PubMed     Abstract available


  27. CONTRERAS-YANEZ I, Guaracha-Basanez G, Pascual-Ramos V
    Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study.
    Rheumatol Int. 2019 Oct 12. pii: 10.1007/s00296-019-04451.
    PubMed     Abstract available


  28. BROM M, Moyano S, Gandino IJ, Scolnik M, et al
    Incidence of cancer in a cohort of patients with primary Sjogren syndrome in Argentina.
    Rheumatol Int. 2019;39:1697-1702.
    PubMed     Abstract available


    September 2019
  29. OLAH C, Kardos Z, Andrejkovics M, Szarka E, et al
    Assessment of cognitive function in female rheumatoid arthritis patients: associations with cerebrovascular pathology, depression and anxiety.
    Rheumatol Int. 2019 Sep 25. pii: 10.1007/s00296-019-04449.
    PubMed     Abstract available


  30. GONZALEZ-CHAVEZ SA, Pacheco-Tena C, de Jesus Caraveo-Frescas T, Quinonez-Flores CM, et al
    Oral health and orofacial function in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Sep 17. pii: 10.1007/s00296-019-04440.
    PubMed     Abstract available


  31. RYDHOLM M, Wikstrom I, Hagel S, Jacobsson LTH, et al
    The relation between upper extremity joint involvement and grip force in early rheumatoid arthritis: a retrospective study.
    Rheumatol Int. 2019 Sep 7. pii: 10.1007/s00296-019-04438.
    PubMed     Abstract available


  32. COONEY JK, Ahmad YA, Moore JP, Sandoo A, et al
    The impact of cardiorespiratory fitness on classical cardiovascular disease risk factors in rheumatoid arthritis: a cross-sectional and longitudinal study.
    Rheumatol Int. 2019 Sep 3. pii: 10.1007/s00296-019-04431.
    PubMed     Abstract available


  33. WEI Z, Jiaying S, Junhong G
    Bilateral facial paralysis as a rare neurological manifestation of primary Sjogren's syndrome: case-based review.
    Rheumatol Int. 2019;39:1651-1654.
    PubMed     Abstract available


  34. OLSSON P, Bodewes ILA, Nilsson AM, Turesson C, et al
    Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjogren's syndrome.
    Rheumatol Int. 2019;39:1575-1584.
    PubMed     Abstract available


  35. OKU K, Atsumi T
    Rheumatology practice in Japan: challenges and opportunities.
    Rheumatol Int. 2019;39:1499-1505.
    PubMed     Abstract available


    August 2019
  36. KLIMENTA B, Nefic H, Prodanovic N, Jadric R, et al
    Association of biomarkers of inflammation and HLA-DRB1 gene locus with risk of developing rheumatoid arthritis in females.
    Rheumatol Int. 2019 Aug 26. pii: 10.1007/s00296-019-04429.
    PubMed     Abstract available


  37. FAVALLI EG, Becciolini A, Carletto A, Conti F, et al
    Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
    Rheumatol Int. 2019 Aug 21. pii: 10.1007/s00296-019-04416.
    PubMed     Abstract available


  38. GO DJ, Lee SJ, Joo SH, Cheon GJ, et al
    Potential clinical utility of a novel optical tomographic imaging for the quantitative assessment of hand rheumatoid arthritis.
    Rheumatol Int. 2019 Aug 21. pii: 10.1007/s00296-019-04424.
    PubMed     Abstract available


  39. ULUTATAR F, Unal-Ulutatar C, Duruoz MT
    Cervical proprioceptive impairment in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Aug 21. pii: 10.1007/s00296-019-04419.
    PubMed     Abstract available


  40. LEE JS, Lim DH, Oh JS, Kim YG, et al
    Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study.
    Rheumatol Int. 2019 Aug 14. pii: 10.1007/s00296-019-04418.
    PubMed     Abstract available


  41. DE AGUSTIN JJ, Erra A, Ponce A, Moragues C, et al
    Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation.
    Rheumatol Int. 2019 Aug 8. pii: 10.1007/s00296-019-04383.
    PubMed     Abstract available


  42. GOMEZ-CENTENO A, Rubio-Romero E, Ovalles JG, Manrique-Arija S, et al
    Clinical and therapeutic management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: RADAR study.
    Rheumatol Int. 2019 Aug 8. pii: 10.1007/s00296-019-04378.
    PubMed     Abstract available


  43. SHRESHER NM, Mohamed AE, Elshahaly MH
    Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Aug 3. pii: 10.1007/s00296-019-04403.
    PubMed     Abstract available


  44. YANG Y, Wang Z, Fu Z, Yang R, et al
    Stiffening of aorta is more preferentially associated with rheumatoid arthritis than peripheral arteries.
    Rheumatol Int. 2019 Aug 2. pii: 10.1007/s00296-019-04405.
    PubMed     Abstract available


    July 2019
  45. COFFEY CM, Davis JM 3rd, Crowson CS
    The impact of gender on time to rheumatoid arthritis classification: a retrospective analysis of a population-based cohort.
    Rheumatol Int. 2019 Jul 23. pii: 10.1007/s00296-019-04360.
    PubMed     Abstract available


  46. KUCHARSKI D, Lange E, Ross AB, Svedlund S, et al
    Moderate-to-high intensity exercise with person-centered guidance influences fatigue in older adults with rheumatoid arthritis.
    Rheumatol Int. 2019 Jul 20. pii: 10.1007/s00296-019-04384.
    PubMed     Abstract available


  47. ALHAJERI H, Abutiban F, Al-Adsani W, Al-Awadhi A, et al
    Kuwait association of rheumatology 2018 treatment recommendations for patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Jul 15. pii: 10.1007/s00296-019-04372.
    PubMed     Abstract available


  48. POPOVA V, Vazhev Z, Geneva-Popova M, Batalov A, et al
    Comparison of RANKL expression, inflammatory markers, and cardiovascular risk in patients with acute coronary syndrome with and without rheumatoid arthritis.
    Rheumatol Int. 2019 Jul 11. pii: 10.1007/s00296-019-04367.
    PubMed     Abstract available


  49. LILA AM, Mazurov VI, Denisov LN, Nesmeyanova OB, et al
    A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.
    Rheumatol Int. 2019 Jul 10. pii: 10.1007/s00296-019-04359.
    PubMed     Abstract available


    June 2019
  50. FOO J, Morel C, Bergman M, Baerwald C, et al
    Cost per response for abatacept versus adalimumab in patients with seropositive, erosive early rheumatoid arthritis in the US, Germany, Spain, and Canada.
    Rheumatol Int. 2019 Jun 25. pii: 10.1007/s00296-019-04352.
    PubMed     Abstract available


  51. SINGH A, Misra R, Aggarwal A
    Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Jun 15. pii: 10.1007/s00296-019-04344.
    PubMed     Abstract available


  52. MICHAEL BNR, Kommoju V, Kavadichanda Ganapathy C, Negi VS, et al
    Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Jun 14. pii: 10.1007/s00296-019-04337.
    PubMed     Abstract available


  53. WU GC, Tao SS, Zhao CN, Mao YM, et al
    Correction: Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis.
    Rheumatol Int. 2019 Jun 6. pii: 10.1007/s00296-019-04342.
    PubMed    


  54. OTON T, Carmona L, Urruticoechea-Arana A, Calvo-Alen J, et al
    Discordance between doctor and patient assessments and non-adherence to subcutaneous biological drugs.
    Rheumatol Int. 2019;39:1077-1082.
    PubMed     Abstract available


  55. VIKSE J, Jonsdottir K, Kvaloy JT, Wildhagen K, et al
    Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases.
    Rheumatol Int. 2019;39:1083-1090.
    PubMed     Abstract available


  56. ROSAS J, Sanchez-Piedra C, Fernandez-Castro M, Andreu JL, et al
    ESSDAI activity index of the SJOGRENSER cohort: analysis and comparison with other European cohorts.
    Rheumatol Int. 2019;39:991-999.
    PubMed     Abstract available


  57. GADEHOLT O, Feuchtenberger M, Wech T, Schwaneck EC, et al
    Power-Doppler perfusion phenotype in RA patients is dependent on anti-citrullinated peptide antibody status, not on rheumatoid factor.
    Rheumatol Int. 2019;39:1019-1025.
    PubMed     Abstract available


    May 2019
  58. DROSOS AA, Pelechas E, Voulgari PV
    Conventional radiography of the hands and wrists in rheumatoid arthritis. What a rheumatologist should know and how to interpret the radiological findings.
    Rheumatol Int. 2019 May 22. pii: 10.1007/s00296-019-04326.
    PubMed     Abstract available


  59. FUJIMORI M, Kamishima T, Narita A, Henmi M, et al
    Quantitative power Doppler signal assessment in the subchondral bone region of the metacarpophalangeal joint is an effective predictor of radiographic progression in the hand of rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2019 May 14. pii: 10.1007/s00296-019-04320.
    PubMed     Abstract available


  60. NOVIKOVA DS, Udachkina HV, Markelova EI, Kirillova IG, et al
    Dynamics of body mass index and visceral adiposity index in patients with rheumatoid arthritis treated with tofacitinib.
    Rheumatol Int. 2019 May 3. pii: 10.1007/s00296-019-04303.
    PubMed     Abstract available


    April 2019
  61. YANG JH, Kwon HH, Lee JK, Bang SY, et al
    Successful arthroscopic treatment of refractory and complicated popliteal cyst associated with rheumatoid arthritis in combination with osteoarthritis: case series and literature review.
    Rheumatol Int. 2019 Apr 11. pii: 10.1007/s00296-019-04278.
    PubMed     Abstract available


  62. WU GC, Tao SS, Zhao CN, Mao YM, et al
    Leveraging Google Trends to investigate the global public interest in rheumatoid arthritis.
    Rheumatol Int. 2019 Apr 6. pii: 10.1007/s00296-019-04297.
    PubMed     Abstract available


  63. VASILEV G, Ivanova M, Ivanova-Todorova E, Tumangelova-Yuzeir K, et al
    Secretory factors produced by adipose mesenchymal stem cells downregulate Th17 and increase Treg cells in peripheral blood mononuclear cells from rheumatoid arthritis patients.
    Rheumatol Int. 2019 Apr 3. pii: 10.1007/s00296-019-04296.
    PubMed     Abstract available


  64. FARA N, Recchia O, Sequeira G, Sanchez K, et al
    Disability due to rheumatic diseases in the city of Junin, Argentina.
    Rheumatol Int. 2019;39:729-733.
    PubMed     Abstract available


  65. NISAR MK
    Early arthritis clinic is effective for rheumatoid and psoriatic arthritides.
    Rheumatol Int. 2019;39:657-662.
    PubMed     Abstract available


    March 2019
  66. BURGHARDT RD, Kazim MA, Ruther W, Niemeier A, et al
    The impact of physical activity on serum levels of inflammatory markers in rheumatoid arthritis: a systematic literature review.
    Rheumatol Int. 2019 Mar 21. pii: 10.1007/s00296-019-04284.
    PubMed     Abstract available


  67. LEE HN, Kim YK, Kim GT, Ahn E, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-alpha agents in patients with rheumatoid arthritis: a retrospective chart review analysis.
    Rheumatol Int. 2019 Mar 14. pii: 10.1007/s00296-019-04276.
    PubMed     Abstract available


  68. UNAL O, Can ME, Ozcan A, Ozcan ME, et al
    Color Doppler imaging of ocular hemodynamic changes in patients with rheumatoid arthritis unrelated to disease activity.
    Rheumatol Int. 2019 Mar 12. pii: 10.1007/s00296-019-04275.
    PubMed     Abstract available


  69. QOROLLI M, Rexhepi B, Rexhepi S, Mustapic M, et al
    Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.
    Rheumatol Int. 2019 Mar 7. pii: 10.1007/s00296-019-04258.
    PubMed     Abstract available


  70. CHANDRASHEKARA S, Shobha V, Rao V, Desai A, et al
    Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India.
    Rheumatol Int. 2019;39:497-507.
    PubMed     Abstract available


  71. JACOB L, Chevalier T, Kostev K
    Persistence with biological drugs in patients treated in rheumatology practices in Germany.
    Rheumatol Int. 2019;39:525-531.
    PubMed     Abstract available


  72. GEORGIEV T, Stoilov R
    Bulgarian rheumatology: science and practice in a cost-constrained environment.
    Rheumatol Int. 2019;39:417-429.
    PubMed     Abstract available


  73. HERNANDEZ MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, et al
    Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
    Rheumatol Int. 2019;39:509-515.
    PubMed     Abstract available


    February 2019
  74. DOKO I, Bajic Z, Dubravic A, Qorolli M, et al
    Hand grip endurance moderating the effect of grip force on functional ability and disease activity in rheumatoid arthritis patients: a cross-sectional study.
    Rheumatol Int. 2019 Feb 12. pii: 10.1007/s00296-019-04250.
    PubMed     Abstract available


  75. BYKERK VP, Burmester GR, Combe BG, Furst DE, et al
    Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
    Rheumatol Int. 2019 Feb 5. pii: 10.1007/s00296-018-4232.
    PubMed     Abstract available


  76. MIYAMOTO ST, Valim V, Carletti L, Ng WF, et al
    Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjogren's syndrome: a randomized-controlled trial.
    Rheumatol Int. 2019;39:227-238.
    PubMed     Abstract available


    January 2019
  77. KAWATKAR AA, Gabriel SE, Jacobsen SJ
    Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system.
    Rheumatol Int. 2019 Jan 17. pii: 10.1007/s00296-018-04235.
    PubMed     Abstract available


  78. TADA Y, Inokuchi S, Maruyama A, Suematsu R, et al
    Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
    Rheumatol Int. 2019;39:97-104.
    PubMed     Abstract available


    December 2018
  79. PFEIL A, Nussbaum A, Renz DM, Jung C, et al
    Inhibition of periarticular bone loss is associated with clinical remission and ACR70-Response in rheumatoid arthritis.
    Rheumatol Int. 2018 Dec 19. pii: 10.1007/s00296-018-4226.
    PubMed     Abstract available


  80. PELECHAS E, Papoudou-Bai A, Voulgari PV, Drosos AA, et al
    Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review.
    Rheumatol Int. 2018 Dec 7. pii: 10.1007/s00296-018-4212.
    PubMed     Abstract available


  81. SALAFFI F, Di Carlo M, Carotti M, Farah S, et al
    Validity and interpretability of the QuickDASH in the assessment of hand disability in rheumatoid arthritis.
    Rheumatol Int. 2018 Dec 3. pii: 10.1007/s00296-018-4216.
    PubMed     Abstract available


    November 2018
  82. TORRENTE-SEGARRA V, Fernandez Prada M, Exposito Moliner R, Garrido Punal NP, et al
    How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol.
    Rheumatol Int. 2018 Nov 24. pii: 10.1007/s00296-018-4205.
    PubMed    


  83. EMMANUEL D, Parija SC, Jain A, Misra DP, et al
    Persistent eosinophilia in rheumatoid arthritis: a prospective observational study.
    Rheumatol Int. 2018 Nov 13. pii: 10.1007/s00296-018-4191.
    PubMed     Abstract available


  84. VELDHUIJZEN VAN ZANTEN JJCS, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, et al
    Comparison of the effects of exercise and anti-TNF treatment on cardiovascular health in rheumatoid arthritis: results from two controlled trials.
    Rheumatol Int. 2018 Nov 12. pii: 10.1007/s00296-018-4183.
    PubMed     Abstract available


  85. KRUGER K, Burmester GR, Wassenberg S, Bohl-Buhler M, et al
    Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany.
    Rheumatol Int. 2018 Nov 10. pii: 10.1007/s00296-018-4180.
    PubMed     Abstract available


  86. GENERALI E, Carrara G, Kallikourdis M, Condorelli G, et al
    Risk of hospitalization for heart failure in rheumatoid arthritis patients treated with etanercept and abatacept.
    Rheumatol Int. 2018 Nov 10. pii: 10.1007/s00296-018-4196.
    PubMed     Abstract available


    October 2018
  87. KISIEL B, Kruszewski R, Juszkiewicz A, Raczkiewicz A, et al
    Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration.
    Rheumatol Int. 2018 Oct 29. pii: 10.1007/s00296-018-4186.
    PubMed     Abstract available


  88. HAYAKAWA M, Izumi K, Higashida-Konishi M, Ushikubo M, et al
    Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2018 Oct 24. pii: 10.1007/s00296-018-4175.
    PubMed     Abstract available


  89. BYKERK VP, Burmester GR, Combe BG, Furst DE, et al
    On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis.
    Rheumatol Int. 2018 Oct 20. pii: 10.1007/s00296-018-4173.
    PubMed     Abstract available


  90. STEFFEN A, Holstiege J, Klimke K, Akmatov MK, et al
    Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data.
    Rheumatol Int. 2018 Oct 10. pii: 10.1007/s00296-018-4161.
    PubMed     Abstract available


  91. CASTREJON I, Shakoor N, Chua JR, Block JA, et al
    Discordance of global assessment by patients and physicians is higher in osteoarthritis than in rheumatoid arthritis: a cross-sectional study from routine care.
    Rheumatol Int. 2018 Oct 6. pii: 10.1007/s00296-018-4166.
    PubMed     Abstract available


    September 2018
  92. MUNOZ-FERNANDEZ S, Oton-Sanchez T, Carmona L, Calvo-Alen J, et al
    Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence.
    Rheumatol Int. 2018 Sep 24. pii: 10.1007/s00296-018-4152.
    PubMed     Abstract available


  93. COSKUN BENLIDAYI I
    Sleep impairment: an obstacle to achieve optimal quality of life in rheumatoid arthritis.
    Rheumatol Int. 2018 Sep 11. pii: 10.1007/s00296-018-4155.
    PubMed     Abstract available


  94. SAIKI O, Uda H
    Efficacy and safety of extending intravenous tocilizumab intervals from 4 to 6 weeks in rheumatoid arthritis patients with good response to 4-week intervals.
    Rheumatol Int. 2018 Sep 11. pii: 10.1007/s00296-018-4149.
    PubMed     Abstract available


  95. MCKENNA S, Tierney M, O'Neill A, Fraser A, et al
    Correction to: Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.
    Rheumatol Int. 2018 Sep 5. pii: 10.1007/s00296-018-4143.
    PubMed     Abstract available


  96. LEE J, Koh JH, Kim JW, Sung YK, et al
    Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome in a Korean cohort.
    Rheumatol Int. 2018;38:1651-1660.
    PubMed     Abstract available


  97. GRIFFITHS AJ, White CM, Thain PK, Bearne LM, et al
    The effect of interactive digital interventions on physical activity in people with inflammatory arthritis: a systematic review.
    Rheumatol Int. 2018;38:1623-1634.
    PubMed     Abstract available


    August 2018
  98. DEMMELMAIER I, Pettersson S, Nordgren B, Dufour AB, et al
    Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis.
    Rheumatol Int. 2018 Aug 29. pii: 10.1007/s00296-018-4140.
    PubMed     Abstract available


  99. SAPUNDZHIEVA T, Karalilova R, Batalov A
    Musculoskeletal ultrasound for predicting remission in patients with rheumatoid arthritis: results from a 1-year prospective study.
    Rheumatol Int. 2018 Aug 18. pii: 10.1007/s00296-018-4131.
    PubMed     Abstract available


  100. OLSSON P, Skogstrand K, Nilsson A, Turesson C, et al
    Smoking, disease characteristics and serum cytokine levels in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2018;38:1503-1510.
    PubMed     Abstract available


  101. KATO M, Yasuda S, Atsumi T
    The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at?
    Rheumatol Int. 2018;38:1333-1338.
    PubMed     Abstract available


    July 2018
  102. YU X, Li Z, Ren M, Xi J, et al
    Superb microvascular imaging (SMI) for evaluating hand joint lesions in patients with rheumatoid arthritis in clinical remission.
    Rheumatol Int. 2018 Jul 30. pii: 10.1007/s00296-018-4112.
    PubMed     Abstract available


  103. SAWADA H, Suda M, Rokutanda R, Kobayashi D, et al
    Concomitant use of intravenous methylprednisolone to increase retention rate of abatacept in rheumatoid arthritis.
    Rheumatol Int. 2018 Jul 27. pii: 10.1007/s00296-018-4115.
    PubMed     Abstract available


  104. CEA-CALVO L, Raya E, Marras C, Salman-Monte TC, et al
    Correction to: The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Rheumatol Int. 2018 Jul 25. pii: 10.1007/s00296-018-4113.
    PubMed     Abstract available


  105. AYRAVAINEN L, Heikkinen AM, Kuuliala A, Ahola K, et al
    Activity of rheumatoid arthritis correlates with oral inflammatory burden.
    Rheumatol Int. 2018 Jul 24. pii: 10.1007/s00296-018-4108.
    PubMed     Abstract available


  106. WALTER MJM, Kuijper TM, Hazes JMW, Weel AE, et al
    Fatigue in early, intensively treated and tight-controlled rheumatoid arthritis patients is frequent and persistent: a prospective study.
    Rheumatol Int. 2018 Jul 16. pii: 10.1007/s00296-018-4102.
    PubMed     Abstract available


  107. YOSHIDA T, Hashimoto M, Kawahara R, Yamamoto H, et al
    Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2018 Jul 4. pii: 10.1007/s00296-018-4095.
    PubMed     Abstract available


    June 2018
  108. CEA-CALVO L, Raya E, Marras C, Salman-Monte TC, et al
    The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Rheumatol Int. 2018 Jun 29. pii: 10.1007/s00296-018-4097.
    PubMed     Abstract available


  109. SALAFFI F, Di Carlo M, Carotti M, Sarzi-Puttini P, et al
    The subjective components of the Disease Activity Score 28-joints (DAS28) in rheumatoid arthritis patients and coexisting fibromyalgia.
    Rheumatol Int. 2018 Jun 28. pii: 10.1007/s00296-018-4096.
    PubMed     Abstract available


  110. MEEK B, Kelder JC, Claessen AME, van Houte AJ, et al
    Rheumatoid factor isotype and Ro epitope distribution in primary Sjogren syndrome and rheumatoid arthritis with keratoconjunctivitis sicca.
    Rheumatol Int. 2018 Jun 23. pii: 10.1007/s00296-018-4090.
    PubMed     Abstract available


  111. VALOR L, Garrido J, Martinez-Estupinan L, Hernandez-Florez D, et al
    Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs.
    Rheumatol Int. 2018 Jun 18. pii: 10.1007/s00296-018-4087.
    PubMed     Abstract available


  112. CASTRO LL, Lanna CCD, Rocha MP, Ribeiro ALP, et al
    Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jun 15. pii: 10.1007/s00296-018-4084.
    PubMed     Abstract available


  113. GUIMARAES MFBR, de Andrade MVM, Machado CJ, Vieira ELM, et al
    Leptin as an obesity marker in rheumatoid arthritis.
    Rheumatol Int. 2018 Jun 11. pii: 10.1007/s00296-018-4082.
    PubMed     Abstract available


  114. BARCELOS F, Martins C, Papoila A, Geraldes C, et al
    Association between memory B-cells and clinical and immunological features of primary Sjogren's syndrome and Sicca patients.
    Rheumatol Int. 2018;38:1063-1073.
    PubMed     Abstract available


  115. FERNANDEZ CASTRO M, Sanchez-Piedra C, Andreu JL, Martinez Taboada V, et al
    Factors associated with severe dry eye in primary Sjogren's syndrome diagnosed patients.
    Rheumatol Int. 2018;38:1075-1082.
    PubMed     Abstract available


  116. MAVROGENI SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, et al
    Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives.
    Rheumatol Int. 2018;38:949-958.
    PubMed     Abstract available


    May 2018
  117. KABUL EG, Aslan UB, Basakci Calik B, Tasci M, et al
    Exploring the relation between impairment rating by DAS-28 and body function, activity participation, and environmental factors based on ICF hand core set in the patient with rheumatoid arthritis.
    Rheumatol Int. 2018 May 30. pii: 10.1007/s00296-018-4060.
    PubMed     Abstract available


  118. LEON L, Redondo M, Fernandez-Nebro A, Gomez S, et al
    Expert recommendations on the psychological needs of patients with rheumatoid arthritis.
    Rheumatol Int. 2018 May 28. pii: 10.1007/s00296-018-4057.
    PubMed     Abstract available


  119. LAUKOVA L, Konecna B, Vlkova B, Mlynarikova V, et al
    Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 May 23. pii: 10.1007/s00296-018-4055.
    PubMed     Abstract available


  120. BISKUP M, Biskup W, Majdan M, Targonska-Stepniak B, et al
    Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity.
    Rheumatol Int. 2018 May 17. pii: 10.1007/s00296-018-4053.
    PubMed     Abstract available


  121. MCKENNA SG, Donnelly AE, Esbensen BA, Fraser AD, et al
    The impact of exercise on sleep (time, quality, and disturbance) in patients with rheumatoid arthritis: a study protocol for a pilot randomised controlled trial.
    Rheumatol Int. 2018 May 15. pii: 10.1007/s00296-018-4052.
    PubMed     Abstract available


  122. UDACHKINA HV, Novikova DS, Popkova TV, Kirillova IG, et al
    Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months.
    Rheumatol Int. 2018 May 11. pii: 10.1007/s00296-018-4045.
    PubMed     Abstract available


  123. NIKFAR S, Saiyarsarai P, Tigabu BM, Abdollahi M, et al
    Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2018 May 8. pii: 10.1007/s00296-018-4041.
    PubMed     Abstract available


  124. MANDAL SK, Sandhya P, Kabeerdoss J, Ramya J, et al
    CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjogren's syndrome.
    Rheumatol Int. 2018;38:831-836.
    PubMed     Abstract available


    April 2018
  125. MEYER PWA, Ally MTM, Hodkinson B, Anderson R, et al
    Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Rheumatol Int. 2018 Apr 30. pii: 10.1007/s00296-018-4036.
    PubMed     Abstract available


  126. BOUTRUP RJ, Farup J, Vissing K, Kjaer M, et al
    Skeletal muscle stem cell characteristics and myonuclei content in patients with rheumatoid arthritis: a cross-sectional study.
    Rheumatol Int. 2018 Apr 12. pii: 10.1007/s00296-018-4028.
    PubMed     Abstract available


  127. DORNER TE, Berner C, Haider S, Grabovac I, et al
    Sexual health in patients with rheumatoid arthritis and the association between physical fitness and sexual function: a cross-sectional study.
    Rheumatol Int. 2018 Apr 11. pii: 10.1007/s00296-018-4023.
    PubMed     Abstract available


  128. RADOVANOVIC-DINIC B, Tesic-Rajkovic S, Zivkovic V, Grgov S, et al
    Clinical connection between rheumatoid arthritis and liver damage.
    Rheumatol Int. 2018 Apr 7. pii: 10.1007/s00296-018-4021.
    PubMed     Abstract available


  129. HIGGINS SC, Adams J, Hughes R
    Measuring hand grip strength in rheumatoid arthritis.
    Rheumatol Int. 2018 Apr 6. pii: 10.1007/s00296-018-4024.
    PubMed     Abstract available


  130. MARTIN-LOPEZ M, Carmona L, Balsa A, Calvo-Alen J, et al
    Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.
    Rheumatol Int. 2018 Apr 3. pii: 10.1007/s00296-018-4022.
    PubMed     Abstract available


    March 2018
  131. BODAKCI E, Uskudar Cansu D, Erturk A, Calisir C, et al
    Can neck pain be an initial symptom of rheumatoid arthritis? A case report and literature review.
    Rheumatol Int. 2018 Mar 27. pii: 10.1007/s00296-018-4019.
    PubMed     Abstract available


  132. FAUTREL B, Alten R, Kirkham B, de la Torre I, et al
    Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis.
    Rheumatol Int. 2018 Mar 21. pii: 10.1007/s00296-018-4005.
    PubMed     Abstract available


  133. TENTEN-DIEPENMAAT M, van der Leeden M, Vliet Vlieland TPM, Roorda LD, et al
    The effectiveness of therapeutic shoes in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2018 Mar 20. pii: 10.1007/s00296-018-4014.
    PubMed     Abstract available


  134. MCKENNA S, Tierney M, O'Neill A, Fraser A, et al
    Sleep and physical activity: a cross-sectional objective profile of people with rheumatoid arthritis.
    Rheumatol Int. 2018 Mar 14. pii: 10.1007/s00296-018-4009.
    PubMed     Abstract available


  135. SALGADO E, Maneiro Fernandez JR, Souto Vilas A, Gomez-Reino JJ, et al
    Spanish transcultural adaptation and validation of the English version of the compliance questionnaire in rheumatology.
    Rheumatol Int. 2018;38:467-472.
    PubMed     Abstract available


    February 2018
  136. MARCHI LF, Paoliello-Paschoalato AB, Oliveira RDR, Azzolini AECS, et al
    Activation status of peripheral blood neutrophils and the complement system in adult rheumatoid arthritis patients undergoing combined therapy with infliximab and methotrexate.
    Rheumatol Int. 2018 Feb 20. pii: 10.1007/s00296-018-3997.
    PubMed     Abstract available


  137. HASEGAWA M, Sakai F, Konda N, Okabayashi A, et al
    CT assessment of axillary lymphadenopathy in patients with rheumatoid arthritis: association with disease activity and severity.
    Rheumatol Int. 2018 Feb 12. pii: 10.1007/s00296-018-3992.
    PubMed     Abstract available


  138. SIALA M, Rihl M, Sellami H, Znazen A, et al
    Detection of Shigella spp. nucleic acids in the synovial tissue of Tunisian rheumatoid arthritis patients and other forms of arthritis by quantitative real-time polymerase chain reaction.
    Rheumatol Int. 2018 Feb 5. pii: 10.1007/s00296-018-3939.
    PubMed     Abstract available


    January 2018
  139. LOPEZ-LONGO FJ, Seoane-Mato D, Martin-Martinez MA, Sanchez-Alonso F, et al
    Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
    Rheumatol Int. 2018 Jan 24. pii: 10.1007/s00296-018-3933.
    PubMed     Abstract available


  140. KARAGULLE M, Kardes S, Karagulle MZ
    Long-term efficacy of spa therapy in patients with rheumatoid arthritis.
    Rheumatol Int. 2018 Jan 11. pii: 10.1007/s00296-017-3926.
    PubMed     Abstract available


  141. WON S, Cho SK, Kim D, Han M, et al
    Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
    Rheumatol Int. 2018 Jan 4. pii: 10.1007/s00296-017-3925.
    PubMed     Abstract available


  142. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Rheumatol Int. 2018 Jan 2. pii: 10.1007/s00296-017-3922.
    PubMed     Abstract available


  143. SIGHART R, Rech J, Hueber A, Blank N, et al
    Evidence for genetic overlap between adult onset Still's disease and hereditary periodic fever syndromes.
    Rheumatol Int. 2018;38:111-120.
    PubMed     Abstract available


    December 2017
  144. PEREZ-ROMAN DI, Ortiz-Haro AB, Ruiz-Medrano E, Contreras-Yanez I, et al
    Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation.
    Rheumatol Int. 2017 Dec 20. pii: 10.1007/s00296-017-3910.
    PubMed     Abstract available


  145. FORSYTH C, Kouvari M, D'Cunha NM, Georgousopoulou EN, et al
    The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies.
    Rheumatol Int. 2017 Dec 18. pii: 10.1007/s00296-017-3912.
    PubMed     Abstract available


  146. SANTOS-MORENO P, Alvis-Zakzuk NJ, Villarreal-Peralta L, Carrasquilla-Sotomayor M, et al
    A comprehensive care program achieves high remission rates in rheumatoid arthritis in a middle-income setting. Experience of a Center of Excellence in Colombia.
    Rheumatol Int. 2017 Dec 16. pii: 10.1007/s00296-017-3903.
    PubMed     Abstract available


  147. OLIVIER N, Burger J, Joubert R, Lubbe M, et al
    Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa.
    Rheumatol Int. 2017 Dec 12. pii: 10.1007/s00296-017-3907.
    PubMed     Abstract available


  148. GIANFRANCESCO MA, Yazdany J, Schmajuk G
    The impact of smoking on disease measures in rheumatoid arthritis: the need for appropriate adjustment of time-varying confounding.
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3902.
    PubMed     Abstract available


  149. KAMATA Y, Minota S
    Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using "National Database of Health Insurance Claims and Specific Health Checkups of Japan".
    Rheumatol Int. 2017 Dec 5. pii: 10.1007/s00296-017-3900.
    PubMed     Abstract available


    November 2017
  150. DO ESPIRITO SANTO RC, Pompermayer MG, Bini RR, Olszewski V, et al
    Neuromuscular fatigue is weakly associated with perception of fatigue and function in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Nov 27. pii: 10.1007/s00296-017-3894.
    PubMed     Abstract available


  151. BAGANZ L, Richter A, Kekow J, Bussmann A, et al
    Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
    Rheumatol Int. 2017 Nov 16. doi: 10.1007/s00296-017-3870.
    PubMed     Abstract available


  152. AKYUZ G, Kenis-Coskun O
    The Efficacy of Tai Chi and Yoga in Rheumatoid Arthritis and Spondyloarthropathies: A narrative biomedical review.
    Rheumatol Int. 2017 Nov 4. doi: 10.1007/s00296-017-3867.
    PubMed     Abstract available


    October 2017
  153. UDACHKINA HV, Novikova DS, Popkova TV, Kirillova IG, et al
    Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.
    Rheumatol Int. 2017 Oct 27. doi: 10.1007/s00296-017-3860.
    PubMed     Abstract available


  154. SKALKOU A, Manoli SM, Sachinidis A, Ntouros V, et al
    Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.
    Rheumatol Int. 2017 Oct 26. doi: 10.1007/s00296-017-3861.
    PubMed     Abstract available


  155. TAN YK, Allen JC Jr, Lye WK, Chew LC, et al
    Greater rheumatoid arthritis joint improvement with more subjects achieving response across improvement categories using novel versus existing ultrasound methods.
    Rheumatol Int. 2017 Oct 20. doi: 10.1007/s00296-017-3857.
    PubMed     Abstract available


  156. LARKIN L, Gallagher S, Fraser A, Kennedy N, et al
    Community-based intervention to promote physical activity in rheumatoid arthritis (CIPPA-RA): a study protocol for a pilot randomised control trial.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3850.
    PubMed     Abstract available


  157. LEE KE, Lee SS
    In reply to the letter to the Editor, "HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis".
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3851.
    PubMed    


  158. WENG J, Wu H, Wang Z
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis: methodological issues.
    Rheumatol Int. 2017 Oct 17. doi: 10.1007/s00296-017-3849.
    PubMed    


  159. KUME K, Amano K, Yamada S, Kanazawa T, et al
    Tofacitinib improves atherosclerosis despite up-regulating serum cholesterol in patients with active rheumatoid arthritis: a cohort study.
    Rheumatol Int. 2017 Oct 14. doi: 10.1007/s00296-017-3844.
    PubMed     Abstract available


  160. QUINTANA-DUQUE MA, Rondon-Herrera F, Calvo-Paramo E, Yunis JJ, et al
    The impact of smoking on disease activity, disability, and radiographic damage in rheumatoid arthritis: is cigarette protective?
    Rheumatol Int. 2017 Oct 11. doi: 10.1007/s00296-017-3845.
    PubMed     Abstract available


  161. BERNARDES M, Vieira T, Lucas R, Pereira J, et al
    Serum serotonin levels and bone in rheumatoid arthritis patients.
    Rheumatol Int. 2017 Oct 9. doi: 10.1007/s00296-017-3836.
    PubMed     Abstract available


    September 2017
  162. LEE KE, Choi SE, Xu H, Kang JH, et al
    HAQ score is an independent predictor of sustained remission in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 27. doi: 10.1007/s00296-017-3833.
    PubMed     Abstract available


  163. SCHIRMER M, Lion V
    Decline of rheumatologic care of nursing home residents with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 8. doi: 10.1007/s00296-017-3810.
    PubMed    


  164. SUGIMOTO N, Nakajima A, Inoue E, Shidara K, et al
    Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 7. doi: 10.1007/s00296-017-3811.
    PubMed     Abstract available


  165. SALAFFI F, Gerardi MC, Atzeni F, Batticciotto A, et al
    The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 5. doi: 10.1007/s00296-017-3792.
    PubMed     Abstract available


  166. YOON BY, Lee JH, Shin SY
    Discrepancy between subjective and objective measures of cognitive impairment in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Sep 4. doi: 10.1007/s00296-017-3806.
    PubMed     Abstract available


    August 2017
  167. LAU CS, Gibofsky A, Damjanov N, Lula S, et al
    Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review.
    Rheumatol Int. 2017 Aug 29. doi: 10.1007/s00296-017-3780.
    PubMed     Abstract available


  168. LUQUE RAMOS A, Albrecht K, Zink A, Hoffmann F, et al
    Rheumatologic care of nursing home residents with rheumatoid arthritis: a comparison of the year before and after nursing home admission.
    Rheumatol Int. 2017 Aug 18. doi: 10.1007/s00296-017-3791.
    PubMed     Abstract available


  169. LI G, Zhao J, Li B, Ma J, et al
    Associations between CCL21 gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.
    Rheumatol Int. 2017 Aug 10. doi: 10.1007/s00296-017-3784.
    PubMed     Abstract available


    July 2017
  170. KIM D, Cho SK, Choi CB, Choe JY, et al
    Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 26. doi: 10.1007/s00296-017-3781.
    PubMed     Abstract available


  171. AZIZIEH FY, Al Jarallah K, Shehab D, Gupta R, et al
    Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 19. doi: 10.1007/s00296-017-3774.
    PubMed     Abstract available


  172. HIRVONEN H, Kautiainen H, Moilanen E, Mikkelsson M, et al
    The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 11. doi: 10.1007/s00296-017-3771.
    PubMed     Abstract available


  173. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
    Rheumatol Int. 2017 Jul 10. doi: 10.1007/s00296-017-3772.
    PubMed     Abstract available


  174. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Jul 5. doi: 10.1007/s00296-017-3769.
    PubMed     Abstract available


    June 2017
  175. GOH LL, Yong MY, See WQ, Chee EYW, et al
    NLRP1, PTPN22 and PADI4 gene polymorphisms and rheumatoid arthritis in ACPA-positive Singaporean Chinese.
    Rheumatol Int. 2017 Jun 26. doi: 10.1007/s00296-017-3762.
    PubMed     Abstract available


  176. MENA-VAZQUEZ N, Manrique-Arija S, Yunquera-Romero L, Urena-Garnica I, et al
    Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
    Rheumatol Int. 2017 Jun 19. doi: 10.1007/s00296-017-3758.
    PubMed     Abstract available


  177. HUSNI ME, Betts KA, Griffith J, Song Y, et al
    Benefit-risk trade-offs for treatment decisions in moderate-to-severe rheumatoid arthritis: focus on the patient perspective.
    Rheumatol Int. 2017 Jun 16. doi: 10.1007/s00296-017-3760.
    PubMed     Abstract available


  178. CARDENAS MJ, de la Fuente S, Castro-Villegas MC, Romero-Gomez M, et al
    Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3757.
    PubMed     Abstract available


  179. PAVELKA K, Akkoc N, Al-Maini M, Zerbini CAF, et al
    Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3749.
    PubMed     Abstract available


    May 2017
  180. WEIJERS L, Baerwald C, Mennini FS, Rodriguez-Heredia JM, et al
    Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
    Rheumatol Int. 2017 May 30. doi: 10.1007/s00296-017-3739.
    PubMed     Abstract available


  181. RONDINA RG, de Mello RAF, Valim V, Lourenco RB, et al
    Discordance between clinical and imaging criteria: assessment by magnetic resonance imaging of the foot of patients with rheumatoid arthritis.
    Rheumatol Int. 2017 May 27. doi: 10.1007/s00296-017-3754.
    PubMed     Abstract available


  182. TZANETAKOS C, Tzioufas A, Goules A, Kourlaba G, et al
    Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.
    Rheumatol Int. 2017 May 18. doi: 10.1007/s00296-017-3736.
    PubMed     Abstract available


  183. MARRAS C, Monteagudo I, Salvador G, de Toro FJ, et al
    Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Rheumatol Int. 2017 May 17. doi: 10.1007/s00296-017-3737.
    PubMed     Abstract available


  184. SONG X, Lin Q
    Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.
    Rheumatol Int. 2017 May 10. doi: 10.1007/s00296-017-3732.
    PubMed     Abstract available


  185. KABASAKAL Y, Kitapcioglu G, Karabulut G, Tezcan M, et al
    Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features.
    Rheumatol Int. 2017;37:675-684.
    PubMed     Abstract available


  186. LLORENTE I, Merino L, Ortiz AM, Escolano E, et al
    Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.
    Rheumatol Int. 2017;37:799-806.
    PubMed     Abstract available


  187. STREVENS BOLMGREN V, Olsson P, Wollmer P, Hesselstrand R, et al
    Respiratory symptoms are poor predictors of concomitant chronic obstructive pulmonary disease in patients with primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:813-818.
    PubMed     Abstract available


    April 2017
  188. HUNTER TM, Boytsov NN, Zhang X, Schroeder K, et al
    Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014.
    Rheumatol Int. 2017 Apr 28. doi: 10.1007/s00296-017-3726.
    PubMed     Abstract available


  189. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Rheumatol Int. 2017 Apr 12. doi: 10.1007/s00296-017-3720.
    PubMed     Abstract available


  190. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3705.
    PubMed     Abstract available


  191. DE MIGUEL E, Pecondon-Espanol A, Castano-Sanchez M, Corrales A, et al
    A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3714.
    PubMed     Abstract available


  192. NG WF, Miller A, Bowman SJ, Price EJ, et al
    Physical activity but not sedentary activity is reduced in primary Sjogren's syndrome.
    Rheumatol Int. 2017;37:623-631.
    PubMed     Abstract available


  193. GARCIA-MONTOYA L, Saenz-Tenorio CN, Janta I, Menarguez J, et al
    Hemophagocytic lymphohistiocytosis in a patient with Sjogren's syndrome: case report and review.
    Rheumatol Int. 2017;37:663-669.
    PubMed     Abstract available


    March 2017
  194. STOLT M, Suhonen R, Leino-Kilpi H
    Foot health in patients with rheumatoid arthritis-a scoping review.
    Rheumatol Int. 2017 Mar 21. doi: 10.1007/s00296-017-3699.
    PubMed     Abstract available


  195. EL-HENAWY AA, Hafez EA, Nabih N, Shalaby NM, et al
    Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients.
    Rheumatol Int. 2017 Mar 20. doi: 10.1007/s00296-017-3703.
    PubMed     Abstract available


    June 2016
  196. JANTA I, Moran J, Naredo E, Nieto JC, et al
    How does a cadaver model work for testing ultrasound diagnostic capability for rheumatic-like tendon damage?
    Rheumatol Int. 2016;36:863-9.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: